Climb Bio, Inc. (CLYM) vs MiMedx Group, Inc (MDXG)
Climb Bio, Inc. and MiMedx Group, Inc are both Biotechnology companies. Climb Bio, Inc. and MiMedx Group, Inc are of similar size ($686.5M and $682.9M). Climb Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. MiMedx Group, Inc has the higher net margin (1.76% vs 0.00%) and the higher return on invested capital (5.62% vs −71.7%). Across the 13 metrics below, MiMedx Group, Inc leads on 10 and Climb Bio, Inc. on 3.
Valuation
Profitability
| Metric | CLYM | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 78.85% | 65.16% |
| Operating margin | 0.00% | 2.46% | 0.00% |
| Net margin | 0.00% | 1.76% | 0.00% |
| Free cash flow margin | 0.00% | 12.51% | 0.00% |
| Return on equity | (27.10%) | 2.88% | (57.72%) |
| Return on assets | (26.27%) | 2.18% | (49.22%) |
| Return on invested capital | (71.73%) | 5.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack